Contractor profile

Leidos Biomedical Research Inc

FY2026 ended Sep 30 · data still posting · data as of 2026-11-01†

† DoD contract data posts to USAspending about 90 days after award.

prime recipient of federal awards · part of Leidos, Inc. Inferred · UEI HV8BH9BPG8Y9 Source
$779.4M
Obligated
FY2026 · data still posting
1
Funding agencies
100%
From Health and Hum…
1
States
100%
In Maryland
2
Industries

In FY2026, Leidos Biomedical Research Inc received $779.4M in federal awards from the Department of Health and Human Services, with 100% of the work performed in Maryland. Across FY2020 to FY2026 its recorded total is $6.5B. FY2026 ended Sep 30 and its data is still posting. Computed

Where this money comes from

Source
FUNDING AGENCIES
LEIDOS BIOMEDICAL RESEAR
HHS
$0.8B
Leidos Biomedical Research Inc
$0.8B
FY2026 obligated
band width = obligations · FY2026 · source: USASpending.gov

Where the work lands

Source
Maryland$779.4M

Key takeaways

Computed
FY2026 ended Sep 30 · data still posting · data as of 2026-11-01
  • Leidos Biomedical Research Inc received $779.4M in federal obligations in FY2026 (data still posting), compared with $572.1M in FY2025.
  • The Department of Health and Human Services accounted for 100% of it.
  • Its largest recorded industry was Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology), at $776.3M.
  • Maryland was its largest place of performance, with 100% of the work.

Obligations by year

Computed
$1.2B
FY20
$934.7M
FY21
$981.7M
FY22
$1.2B
FY23
$869.3M
FY24
$572.1M
FY25
$779.4M
FY26 partial
▼ 51%
FY20 to FY25

Awards

Source

Largest active awards by total value

Awards whose period of performance overlaps FY2026, by the amount obligated on each so far.

AwardIDAgencyObligatedStartEndPlace
NCI Operational Task Order, FY26-FY2775N91025F00016Department of Health and Human Services$826M2025-08-312027-08-30Maryland
NCI Operational Task Order75N91019F00129Department of Health and Human Services$432.4M2019-08-312026-05-21Maryland
Contract 75N91019F0013975N91019F00139Department of Health and Human Services$181.4M2019-09-262029-10-31Maryland
Objective of This Task Order Supports Niaids Goal to Conduct a Series of Standardized…75N91023F00008Department of Health and Human Services$173.3M2023-06-012029-05-31Maryland
NIAID COVID-19 ACTIV375N91020F00039Department of Health and Human Services$159.1M2020-09-022027-02-28Maryland
Advance Universal Influenza Vaccine - Flu Mosaic Version 2 (FLUMOSV2)75N91021F00004Department of Health and Human Services$141.7M2021-02-162031-01-28Maryland
NIAID DCR FY26-27 Operational Task Order75N91025F00012Department of Health and Human Services$137.7M2025-08-312026-08-30Maryland
Enabling NCI Clinical & Research Data Sharing75N91021F00013Department of Health and Human Services$98.6M2021-08-312028-02-28Maryland

Largest FY2026 awards

Awards that started in FY2026, by the amount obligated on each so far.

AwardIDAgencyObligatedStartEndPlace
Functional Precision Medicine and Response Assays75N91026F00034Department of Health and Human Services$72.2M2026-09-292031-09-28Maryland

What it does (NAICS / PSC)

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)$776.3M
Facilities Support Services$3.1M

Corporate family

Part ofLeidos, Inc. →Inferred

One registration (UEI HV8BH9BPG8Y9) of the combined recipient above.

Related

Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.